Stop Taking This Weight Loss Pill The US Food and Drug Administration (FDA) warned consumers and healthcare professionals on November 20, to immediately stop the use of a weight loss aid marketed under the name Lipokinetix by Cape Girardeau, Missouri-based Syntrax Innovations Inc. The FDA said it has received at least six reports of individuals suffering acute liver failure associated with the dietary supplement. All were between 20 and 32 years old. In issuing the warning on Lipokinetix, the FDA encouraged consumers to consult a physician if they have experienced nausea, weakness, fatigue, fever, abdominal pain or any change in skin color. The FDA also encouraged consumers and physicians to report any cases of liver injury or other side effects that may be related to the dietary supplement. The FDA said reports could be made by telephone at 1-800-332-1088 or on the Internet at www.fda.gov/medwatch. (end) Khorsheed.com - Dec 2001